Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. Adrenal cortex. Second edition.
|Published (Last):||15 April 2012|
|PDF File Size:||7.49 Mb|
|ePub File Size:||6.11 Mb|
|Price:||Free* [*Free Regsitration Required]|
Santiago de Chile. Primary aldosteronism PA is a known cause of hypertension. In the kidney, aldosterone promotes sodium and water reabsorption, increasing the intravascular volume and blood pressure BP.
In the cardiovascular system, aldosterone modifies endothelial and smooth muscle cell response, increasing cardiovascular risk in a blood pressure-independent way. This ratio increases along with the severity ofthe hypertensive disease. The diagnostic work up of PA should confirm the autonomy of aldosterone secretion from the renin-angiotensin system and should differentiate the clinical subtypes of the disease.
Other causes are familial hyperaldosteronism FH type I glucocorticoid-remediable aldosteronism , FH-II non glucocorticoid-remediable aldosteronism , primary adrenal hyperplasia and adrenal carcinoma. This article reviews the prevalence, diagnosis and treatment of PA and also the clinical, biochemical and genetic characteristics ofits different subtypes.
Key words: Aldosterone; Hyperaldosteronism; Hypertension. Estos datos apuntan a un nuevo rol de la aldosterona frente al metabolismo de los hidratos de carbono. Otras causas son el hiperaldosteronismo familiar tipo I HF-I aldosteronismo remediable por glucocorticoides y el HF-II aldosteronismo no remediable por glucocorticoides , la hiperplasia adrenal primaria y el carcinoma suprarrenal ACTH , por lo cual los pacientes afectados pueden ser tratados con glucocorticoides.
El HFTI puede presentarse como una hiperplasia adrenocortical bilateral o como un adenoma. Screening del hiperaldosteronismo primario. Test confirmatorios de hiperaldosteronismo primario. Muestreo de venas suprarrenales MVS. La espironolactona, un antagonista de la aldosterona a nivel de su receptor, ha sido la droga tradicional-mente usada.
La sospecha de hiperaldosteronismo debe certificarse usando tests confirmatorios fludrocortisona o sobrecarga salina. Global burden of hypertension: analysis of worldwide data. Lancet ; New genetic insights in familial hyperaldosteronism. Ann N YAcad Sci ; Nor-mokalemic Primary Aldosteronism. JAMA ; Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from through Mayo Clin Proc ; Diagnosis and treatment of primary hyperaldosteronism.
Ann Intern Med ; Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.
J Clin Endocrinol Metab ; Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens ; Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and compara-tive studies on various causes of primary aldosteronism in Yokohama Rosai Hospital.
Biomed Pharmacother ; 54 Suppl 1: 83ss. S Afr Med J ; Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
Am J Kidney Dis ; Clin Chem ; Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension ; Primary aldosteronism and hypertensive disease. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens ; High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
J Hypertens ; Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res ; Primary Hyperaldosteronism in the Hypertensive Disease. Curr Hypertens Reviews ; 2: Kaplan NM. Cautions over the current epidemic of primary aldosteronism. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.
Randomized Aldactone Evaluation Study Investigators. N Engl J Med ; Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
J Am Coll Cardiol ; Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. Cooper ME. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Nongenomic vascular action of aldosterone in the glomerular microcirculation.
J Am Soc Nephrol ; Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci ; Characterization of two genes encoding human steroid 11 beta-hydroxylase P ll beta. J Biol Chem ; Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. Vallotton MB. Primary aldosteronism. Part II. Differential diagnosis of primary hyperaldosteronism and pseudoaldosteronism.
Clin Endocrinol Oxf ; Part I. Diagnosis of primary hyperaldosteronism. Gordon RD. J Endocrinol Invest ; Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta PRKAR1B on 7p no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred.
Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.
A methodological improvement]. Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med ; Gill J. In: Becker K, ed. Principies and practice of endocrinology and metabolism. Philadelphia: JB Lippincott Company Ganguly A. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens ; 3: Studies of the control of plasma aldosterone concentration in normal man.
Response to sodium chloride infusion. J Clin Invest ; Glucocorticoid-remediable aldosteronism GRA : diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids ;
2015, Número 3
Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension. Diniz 5. Objective: The aim of this article is to highlight the importance of a rare disease that causes severe arterial hypertension in children. It is important to advise pediatricians to measure arterial pressure in children in order to avoid late diagnosis and renal insufficiency. The diagnosis was established based on the clinical picture associated with the presence of chronic hypokalemia, increase of urinary potassium excretion with sodium retention and reduction of renin plasma activity, and circulating levels of angiotensin II and aldosterone.
Santiago de Chile. Primary aldosteronism PA is a known cause of hypertension. In the kidney, aldosterone promotes sodium and water reabsorption, increasing the intravascular volume and blood pressure BP. In the cardiovascular system, aldosterone modifies endothelial and smooth muscle cell response, increasing cardiovascular risk in a blood pressure-independent way. This ratio increases along with the severity ofthe hypertensive disease. The diagnostic work up of PA should confirm the autonomy of aldosterone secretion from the renin-angiotensin system and should differentiate the clinical subtypes of the disease. Other causes are familial hyperaldosteronism FH type I glucocorticoid-remediable aldosteronism , FH-II non glucocorticoid-remediable aldosteronism , primary adrenal hyperplasia and adrenal carcinoma.
Marta Liliane A. Maia I ; Maria Luiza D. Carvalhaes V. Proesmans W. Threading through the mizmaze of Bartter syndrome. Pediatr Nephrol ; Bartter's syndrome.